11 Analysts Have This to Say About Travere Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published their opinions on Travere Therapeutics (NASDAQ:TVTX) stock, with an average price target of $32.36, representing an upside from the current price of $16.93. The current average represents a 16.49% decrease from the previous average price target of $38.75.
May 22, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
11 analysts have a bullish outlook on Travere Therapeutics (NASDAQ:TVTX) with an average price target of $32.36, indicating potential upside from the current price of $16.93.
The article mentions that 11 analysts have published their opinions on Travere Therapeutics (NASDAQ:TVTX) stock over the past 3 months. The average price target of $32.36 represents an upside from the current price of $16.93. This indicates a positive outlook for the stock in the short term, as the majority of analysts have a bullish stance on the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100